Literature DB >> 8879117

Functional analysis of simian immunodeficiency virus SIVAGM long terminal repeat.

J Sakuragi1, S Sakuragi, S Ueda, A Adachi.   

Abstract

We have previously shown that long terminal repeats (LTRs) derived from various isolates of SIVAGM share a unique functional property. In the absence of viral Tat, all SIVAGM LTRs act as much more efficient promoters than any of the other LTRs derived from representative primate immunodeficiency viruses. In the presence of Tat, however, SIVAGM LTRs are activated relatively inefficiently. To map the elements that confer these features on the SIVAGM LTR, a number of deletion mutants were constructed, and their promoter activities were determined using a bacterial CAT gene as a marker. The results obtained indicated that various elements located in the U3 region may contribute to the high basal promoter activity and that no negative elements are present in the region. The Tat-responsive sequence TAR was localized to the R region as observed for the other LTRs. A mutant carrying a single nucleotide deletion in this region completely lost responsiveness to Tat protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879117     DOI: 10.1007/bf00369997

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  17 in total

1.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

2.  HIV-1 origins. A finger on the missing link.

Authors:  R C Desrosiers
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

3.  A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation.

Authors:  S Roy; U Delling; C H Chen; C A Rosen; N Sonenberg
Journal:  Genes Dev       Date:  1990-08       Impact factor: 11.361

4.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

5.  An inducible transcription factor activates expression of human immunodeficiency virus in T cells.

Authors:  G Nabel; D Baltimore
Journal:  Nature       Date:  1987 Apr 16-22       Impact factor: 49.962

6.  Rev-dependency of expression of human immunodeficiency virus type 1 gag and env genes.

Authors:  H Sakai; R A Furuta; K Tokunaga; M Kawamura; M Hatanaka; A Adachi
Journal:  FEBS Lett       Date:  1995-05-29       Impact factor: 4.124

7.  DNA transfection of mouse lymphoid cells by the combination of DEAE-dextran-mediated DNA uptake and osmotic shock procedure.

Authors:  T Takai; H Ohmori
Journal:  Biochim Biophys Acta       Date:  1990-01-30

8.  Functional analysis of long terminal repeats derived from four strains of simian immunodeficiency virus SIVAGM in relation to other primate lentiviruses.

Authors:  J Sakuragi; M Fukasawa; R Shibata; H Sakai; M Kawamura; H Akari; T Kiyomasu; A Ishimoto; M Hayami; A Adachi
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

Review 10.  Compatibility of Tat and Rev transactivators in the primate lentiviruses.

Authors:  H Sakai; J Sakuragi; S Sakuragi; M Kawamura; A Adachi
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more
  1 in total

1.  Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.

Authors:  H Chen; J He; S Fong; G Wilcox; C Wood
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.